The COVID-19 pandemic has disrupted the supply chain of domestic pharmaceutical raw materials, where 95% of the fulfillment of raw materials relies on imports. Amid difficulties in meeting raw materials, the pharmaceutical sub-sector companies have become one of the sectors of choice for investors throughout 2020, in line with the sentiment of the COVID-19 pandemic. As one of the prima donnas’ sectors during pandemic, financial reports presented by pharmaceutical sector should report the actual condition of the company. This study aims to empirically examine the differences in accrual earnings management before and after the COVID-19 pandemic in pharmaceutical sub-sector companies in Indonesia. To evaluate changes in accrual earnings manage...
Toyyib, 2022, Analysis of the Financial Performance of Pharmaceutical Industry Companies During the ...
Financial performance is a reference that the company wants to achieve in the future within a certai...
Since the emergence of COVID-19 in Indonesia, several corporate sectors in Indonesia have had their ...
The COVID-19 pandemic has disrupted the supply chain of domestic pharmaceutical raw materials, where...
During the COVID-19 pandemic, the pharmaceutical industry became a priority sector for the governmen...
The Covid-19 pandemic has disrupted supply chains both locally and globally, financial market volati...
The COVID-19 pandemic, which began in the first quarter (Q1) of 2020 in Indonesia, has certainly had...
The COVID-19 pandemic hit Indonesia in 2020, and some pharmaceutical companies were impacted like PT...
The purpose of the study was to see differences in financial performance before and when the covid-1...
The purpose of the study was to determine the differences in the financial performance of companies ...
The purpose of this study is to analyze the financial performance of pharmaceutical companies before...
This research aims to analyze the early impact of the COVID-19 pandemic on the tendency of earnings ...
This research was conducted to obtain empirical evidence of the practice of earning management and t...
This study aims to investigate the difference of financial performances public companies in Indonesi...
At the end of 2019, the world was startled by the emergence of a new disease caused by the Sars CoV-...
Toyyib, 2022, Analysis of the Financial Performance of Pharmaceutical Industry Companies During the ...
Financial performance is a reference that the company wants to achieve in the future within a certai...
Since the emergence of COVID-19 in Indonesia, several corporate sectors in Indonesia have had their ...
The COVID-19 pandemic has disrupted the supply chain of domestic pharmaceutical raw materials, where...
During the COVID-19 pandemic, the pharmaceutical industry became a priority sector for the governmen...
The Covid-19 pandemic has disrupted supply chains both locally and globally, financial market volati...
The COVID-19 pandemic, which began in the first quarter (Q1) of 2020 in Indonesia, has certainly had...
The COVID-19 pandemic hit Indonesia in 2020, and some pharmaceutical companies were impacted like PT...
The purpose of the study was to see differences in financial performance before and when the covid-1...
The purpose of the study was to determine the differences in the financial performance of companies ...
The purpose of this study is to analyze the financial performance of pharmaceutical companies before...
This research aims to analyze the early impact of the COVID-19 pandemic on the tendency of earnings ...
This research was conducted to obtain empirical evidence of the practice of earning management and t...
This study aims to investigate the difference of financial performances public companies in Indonesi...
At the end of 2019, the world was startled by the emergence of a new disease caused by the Sars CoV-...
Toyyib, 2022, Analysis of the Financial Performance of Pharmaceutical Industry Companies During the ...
Financial performance is a reference that the company wants to achieve in the future within a certai...
Since the emergence of COVID-19 in Indonesia, several corporate sectors in Indonesia have had their ...